143 related articles for article (PubMed ID: 23815775)
1. Identification of human immunodeficiency virus type 1 (HIV-1) gp120-binding sites on scavenger receptor cysteine rich 1 (SRCR1) domain of gp340.
Chu Y; Li J; Wu X; Hua Z; Wu Z
J Biomed Sci; 2013 Jul; 20(1):44. PubMed ID: 23815775
[TBL] [Abstract][Full Text] [Related]
2. gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction.
Wu Z; Golub E; Abrams WR; Malamud D
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):600-7. PubMed ID: 15242536
[TBL] [Abstract][Full Text] [Related]
3. The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood.
Endrich MM; Gehring H
Eur J Biochem; 1998 Mar; 252(3):441-6. PubMed ID: 9546659
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
Neurath AR; Strick N; Debnath AK
J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
[TBL] [Abstract][Full Text] [Related]
5. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
Tugarinov V; Zvi A; Levy R; Hayek Y; Matsushita S; Anglister J
Structure; 2000 Apr; 8(4):385-95. PubMed ID: 10801487
[TBL] [Abstract][Full Text] [Related]
6. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ
Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Labrosse B; Treboute C; Brelot A; Alizon M
J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of anti-HIV activity of succinylated human serum albumin.
Kuipers ME; vd Berg M; Swart PJ; Laman JD; Meijer DK; Koppelman MH; Huisman H
Biochem Pharmacol; 1999 Apr; 57(8):889-98. PubMed ID: 10086322
[TBL] [Abstract][Full Text] [Related]
9. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor.
Cormier EG; Dragic T
J Virol; 2002 Sep; 76(17):8953-7. PubMed ID: 12163614
[TBL] [Abstract][Full Text] [Related]
10. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
Golding B; Inman J; Highet P; Blackburn R; Manischewitz J; Blyveis N; Angus RD; Golding H
J Virol; 1995 Jun; 69(6):3299-307. PubMed ID: 7745677
[TBL] [Abstract][Full Text] [Related]
11. Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells.
Callebaut C; Blanco J; Benkirane N; Krust B; Jacotot E; Guichard G; Seddiki N; Svab J; Dam E; Muller S; Briand JP; Hovanessian AG
J Biol Chem; 1998 Aug; 273(34):21988-97. PubMed ID: 9705340
[TBL] [Abstract][Full Text] [Related]
12. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.
Zwick MB; Kelleher R; Jensen R; Labrijn AF; Wang M; Quinnan GV; Parren PW; Burton DR
J Virol; 2003 Jun; 77(12):6965-78. PubMed ID: 12768015
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
[TBL] [Abstract][Full Text] [Related]
14. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
15. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.
Yahi N; Sabatier JM; Nickel P; Mabrouk K; Gonzalez-Scarano F; Fantini J
J Biol Chem; 1994 Sep; 269(39):24349-53. PubMed ID: 7929093
[TBL] [Abstract][Full Text] [Related]
16. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.
Rizzuto CD; Wyatt R; Hernández-Ramos N; Sun Y; Kwong PD; Hendrickson WA; Sodroski J
Science; 1998 Jun; 280(5371):1949-53. PubMed ID: 9632396
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection.
Wu Z; Lee S; Abrams W; Weissman D; Malamud D
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):508-15. PubMed ID: 16796526
[TBL] [Abstract][Full Text] [Related]
18. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
Chersi A; Pugliese O; Federico A; Viora M
Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
[TBL] [Abstract][Full Text] [Related]
19. Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340.
Loimaranta V; Hytönen J; Pulliainen AT; Sharma A; Tenovuo J; Strömberg N; Finne J
J Biol Chem; 2009 Jul; 284(28):18614-23. PubMed ID: 19465482
[TBL] [Abstract][Full Text] [Related]
20. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1.
Stoiber H; Schneider R; Janatova J; Dierich MP
Immunobiology; 1995 Jun; 193(1):98-113. PubMed ID: 7590866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
